BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3245376)

  • 1. [Immunogenetic markers of disseminated sclerosis in western Siberia].
    Prokof'ev VF; Gribacheva IA; Konenkov VI; Doronin BM; Voronova IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):49-52. PubMed ID: 3245376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinico-immunologic parallels in multiple sclerosis].
    Prokof'ev VF; Konenkov VI; Gribacheva IA; Voronova IA; Doronin BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):31-4. PubMed ID: 2728717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of immunogenetic typing of lymphocytes of patients with keratoconus].
    Gorskova EN; Tarasova LN; Teplova SN; Sevost'ianov EN
    Vestn Oftalmol; 1998; 114(2):50-2. PubMed ID: 9621825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing histocompatibility antigens (loci A and B) in a group of type 1 (insulin-dependent) diabetic patients in Bucharest.
    Mincu I; Cheţa D; Truia CI; Truia M; Ionescu-Tîrgovişte C; Ilinca D
    Med Interne; 1985; 23(3):207-11. PubMed ID: 4048801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between HLA antigens and leukemia in the population of Vojvodina].
    Vojvodić S; Belić B; Popović S
    Med Pregl; 2001; 54(3-4):128-34. PubMed ID: 11759203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of the major histocompatibility complex-human leukocyte antigen in the Madeconian population].
    Kolevski P; Ivanovski N; Hristova-Dimceva A; Penev M; Cakalaroski K; Lekovski L; Popov Z
    Ann Urol (Paris); 2000 Oct; 34(5):306-11. PubMed ID: 11144717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of HLA alleles with pathological parameters in breast cancer].
    Korotkova IIu; Aumenshlius AI; Ageeva TA; Konenkov VI
    Vopr Onkol; 2009; 55(6):727-32. PubMed ID: 20210016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between insulin antibodies and the HLA system in a group of type I diabetic patients in Bucharest.
    Ionescu-Tîrgovişte C; Cheţa D; Truia CI; Truia M; Mirodon Z; Ilinca D; Cheţa N; Mincu I
    Med Interne; 1986; 24(1):11-7. PubMed ID: 3704498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated sclerosis. Possible correlation between clinical forms and HLA groups (author's transl)].
    Madigand M; Fauchet R; Oger J; Sabouraud O
    Nouv Presse Med; 1981 Jun; 10(28):2349-52. PubMed ID: 7267340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
    Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
    Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA antigen distribution in Jain population from Mumbai, Maharashtra, India.
    Chhaya SU; Shankarkumar U
    Indian J Med Res; 2001 Jul; 114():25-9. PubMed ID: 11762203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Associations of HLA class I haplotype antigens with various patterns of keratoconus].
    Gorskova EN; Sevost'ianov EN
    Vestn Oftalmol; 1997; 113(6):31-3. PubMed ID: 9483998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
    Shiralieva RK; Guseĭnova KA
    Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigen segregation analysis in multiple sclerosis (MS) families.
    Bertrams J; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Change in the incidence of HL-A antigens in diabetes mellitus].
    Serova LD; Shabalin VN; Orkodashvili LSh; Isakov AV
    Probl Endokrinol (Mosk); 1980; 26(2):12-5. PubMed ID: 6154926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunogenetic prognosis and long-term results of surgery for gastric cancer].
    Korotkova IIu; Egorov DN; Solov'eva IG; Cherenkova MM; Vardosanidze KV; Abramov V; Konenkov VI
    Vopr Onkol; 2005; 51(6):672-9. PubMed ID: 17037033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.